Subscribe

IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV12I7A151

Transcatheter aortic valve implantation: the importance of an experienced multidisciplinary team

María Thiscal López-Lluva*, MD; Alfonso Jurado-Román, MD; Ignacio Sánchez-Pérez, MD; Javier Jiménez-Díaz, MD; Manuel Marina-Breysse, MD; Natalia Pinilla-Echeverri, MD; Jesús Piqueras-Flores, MD; Verónica Hernández-Jiménez, MD; Fernando Lozano-Ruiz-Poveda, MD

Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for patients deemed too high-risk for surgery. A significant learning curve has been reported. Not only the implantation but also the subsequent management are crucial. We present an 83-year-old female with severe symptomatic aortic stenosis and a logistic EuroSCORE of 28%, who underwent successful transfemoral CoreValve® (Medtronic, Minneapolis, MN, USA) implantation (Panel A, Moving image 1, Moving image 2). One day after the procedure, she developed a third-degree atrioventricular block. A temporary pacemaker lead was inserted. The procedure was difficult and many intracardiac manipulations were needed. Four hours later, a complete loss of ventricular capture was observed, so she underwent an urgent repositioning. Once again it was difficult and the physician decided to use a subclavian vein access. Minutes later the patient developed symptomatic hypotension, sharp chest pain and dyspnoea. An anteroposterior chest X-ray showed a left pneumothorax with lung collapse (Panel B). Myocardial perforation was also suspected and a bedside echocardiography revealed a large pericardial effusion with signs of tamponade (Panel C). An emergent pericardiocentesis was performed; however, the patient did not improve as expected and a computed tomography scan was done. It showed the drainage catheter inadvertently inserted into the inferior vena cava (Panel D). Despite emergent radioscopically guided repositioning of the catheter, the patient died.

The growing experience with TAVI procedures has increased the implantation success rate and in-cathlab complications are reducing. However, procedure-related complication risks do not end after a successful implantation but rather continue during the post-implantation period. An experienced multidisciplinary team is essential.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Angiography of CoreValve position after successful implantation.

Moving image 2. Trivial aortic regurgitation after TAVI.

Supplementary data

To read the full content of this article, please download the PDF.

Angiography of CoreValve position after successful implantation.

Trivial aortic regurgitation after TAVI.

Volume 12 Number 7
Sep 18, 2016
Volume 12 Number 7
View full issue


Key metrics

Suggested by Cory

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00647 Jan 19, 2018
Percutaneous closure of subannular rupture following transcatheter aortic valve implantation
Shah S et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY15M06_01 Mar 18, 2016
How to overcome a scary complication: a mesh-trapped balloon during a CoreValve® implantation procedure
Bayet G et al
free

10.4244/EIJY14M09_04 Mar 20, 2015
How should I treat dislocation of a TAVI SAPIEN prosthesis into the left ventricle?
Tiroch K et al
free
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
How was the initial TAVI procedure performed and what were the results?
What complication arose one day after the procedure?
How was it initially managed?
What further complication occurred and how was it managed?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved